2019
Gonadotropin-Releasing Hormone Analogs for Gonadal Protection During Gonadotoxic Chemotherapy: A Systematic Review and Meta-Analysis
Sofiyeva N, Siepmann T, Barlinn K, Seli E, Ata B. Gonadotropin-Releasing Hormone Analogs for Gonadal Protection During Gonadotoxic Chemotherapy: A Systematic Review and Meta-Analysis. Reproductive Sciences 2019, 26: 939-953. PMID: 30270741, DOI: 10.1177/1933719118799203.Peer-Reviewed Original ResearchConceptsGonadotropin-releasing hormone analogueSystematic reviewGonadotoxic chemotherapyHormone analogueRisk ratioGnRH agonist-treated patientsGonadotropin-Releasing Hormone AnalogLow-quality evidenceReproductive-aged womenConfidence intervalsSignificant protective effectGonadoprotective effectPresent systematic reviewGnRHa cotreatmentGonadal protectionSupradiaphragmatic radiotherapyCohort studyTrials RegistryGnRHa administrationMenstrual resumptionAutoimmune diseasesSubgroup analysisBreast cancerProtective effectHematological malignancies
2005
Fertility preservation options for female patients with malignancies
Seli E, Tangir J. Fertility preservation options for female patients with malignancies. Current Opinion In Obstetrics & Gynecology 2005, 17: 299-308. PMID: 15870565, DOI: 10.1097/01.gco.0000169108.15623.34.Peer-Reviewed Original ResearchConceptsFemale patientsFertility preservationOocyte cryopreservationOvarian tissueGonadotropin-releasing hormone agonistRadical vaginal trachelectomyInitiation of chemotherapyFertility preservation optionsOvarian stimulation protocolsPreservation of fertilityCryopreserved ovarian tissueFirst embryo transferEmbryo cryopreservationImportant health issueVaginal trachelectomyConservative surgeryGynecologic malignanciesEndometrial cancerOvarian cryopreservationHormone agonistCervical cancerFirst pregnancyProgestin treatmentOvarian tumorsOrthotopic transplantation